Literature DB >> 17954295

D-Penicillamine-induced ANCA-associated crescentic glomerulonephritis in Wilson disease.

Frank Bienaimé1, Gaétan Clerbaux, Emmanuelle Plaisier, Béatrice Mougenot, Pierre Ronco, Jean-Philippe Rougier.   

Abstract

Several drugs, including hydralazine and propylthiouracil, can induce antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. d-Penicillamine was implicated in a few patients with rheumatoid arthritis or systemic sclerosis, but in patients with both diseases, ANCA-associated vasculitides were described in the absence of the drug. Therefore, the role of d-penicillamine treatment could not be established. We report the first case of antimyeloperoxidase antibody-associated vasculitis in a patient treated with d-penicillamine for Wilson disease. Because Wilson disease was never associated with ANCA-related nephritis, this case strongly supports that d-penicillamine can induce ANCA-vasculitis. The presentation and rapidly progressive and potentially severe outcome of this complication dramatically contrast with those of membranous and minimal change glomerulopathy, also induced by the sulfhydryl compound.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17954295     DOI: 10.1053/j.ajkd.2007.05.026

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  17 in total

Review 1.  Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Min Chen; Ying Gao; Xiao-Hui Guo; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2012-06-05       Impact factor: 28.314

2.  D-penicillamine induced membranous glomerulonephritis in a child with Wilson's disease.

Authors:  G Theodoni; N Printza; S Karyda; A Pantzaki; F Papachristou
Journal:  Hippokratia       Date:  2012-01       Impact factor: 0.471

3.  Rare adverse effect of a common drug: nitrofurantoin-induced ANCA-associated vasculitis.

Authors:  Abhishek Agarwal; Abhinav Agrawal; Karim Nathan; Satyajeet Roy
Journal:  BMJ Case Rep       Date:  2015-05-02

Review 4.  Clinical management of Wilson disease.

Authors:  Peter Hedera
Journal:  Ann Transl Med       Date:  2019-04

5.  ANCA-associated vasculitis in systemic sclerosis report of 3 cases.

Authors:  Mohammed A Omair; Nasreen Mohamed; Sindhu R Johnson; Zareen Ahmad; Peter Lee
Journal:  Rheumatol Int       Date:  2012-01-12       Impact factor: 2.631

6.  Prevalence of overlap of antineutrophil cytoplasmic antibody associated vasculitis with systemic autoimmune diseases: an unrecognized example of poliautoimmunity.

Authors:  Eduardo Martín-Nares; Diego Zuñiga-Tamayo; Andrea Hinojosa-Azaola
Journal:  Clin Rheumatol       Date:  2018-07-14       Impact factor: 2.980

7.  D-penicillamine in Wilson's disease; recognizing the transition from benefit to harm.

Authors:  Yihui Goh; Benjamin Yong-Qiang Tan; Nicole Ya-Yuan Chong; Margaret Ma; Manjari Lahiri; Andrew Makmur; Yee Cheun Chan; Soon Boon Justin Wong; Joy Vijayan
Journal:  eNeurologicalSci       Date:  2021-02-15

8.  ANCA-associated Goodpasture's syndrome in a patient with rheumatoid arthritis on penicillamine.

Authors:  R Sharma; S Jain; V Kher
Journal:  Indian J Nephrol       Date:  2012-01

9.  Advance in the pathogenesis and treatment of Wilson disease.

Authors:  Qin-Yun Dong; Zhi-Ying Wu
Journal:  Transl Neurodegener       Date:  2012-11-27       Impact factor: 8.014

10.  D-penicillamine-induced glomerulonephritis with crescent formation: Remission following drug discontinuation.

Authors:  S Mokuda; M Onishi; K Takasugi
Journal:  Indian J Nephrol       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.